0000000001315625

AUTHOR

Evelyne Kohli

showing 28 related works from this author

Inhibition of in vitro reconstitution of rotavirus transcriptionally active particles by anti-VP6 monoclonal antibodies

1994

International audience; Six monoclonal antibodies specific for the major capsid protein of rotavirus, VP6, previously characterized, were tested in a biological assay for their capacity to block the transcriptase activity associated with the single-shelled particles. The results showed that two MAbs (RV-50 and RV-133), specific for distinct antigenic sites, were able to block the transcription when they were incubated with a purified baculovirus-expressed group A VP6, prior to the reconstitution of the single-shelled particles from the cores, suggesting that at least two domains are involved in active single-shelled particle reconstitution. The results obtained previously from immunochemist…

RotavirusTranscription Geneticmedicine.drug_classvirusesBiologyMothsMonoclonal antibodymedicine.disease_causeTransfectionAntiviral AgentsCell Line03 medical and health sciencesCapsidAntigenTranscription (biology)VirologyRotavirusImmunochemistrymedicineAnimalsRNA MessengerAntigens Viral030304 developmental biology0303 health sciences030306 microbiologyAntibodies MonoclonalBiological activityRNA-Directed DNA PolymeraseGeneral MedicineDNA-Directed RNA PolymerasesBIOLOGIE MOLECULAIREChromatography Ion ExchangeVirologyMolecular biologyIn vitro3. Good healthVIROLOGIECapsid[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyChromatography GelCapsid ProteinsBaculoviridae
researchProduct

Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and wit…

2013

International audience; In this study, we compared both the profile and distribution of antigen specific primed T cells after intrarectal (IR) and intranasal (IN) immunization with rotavirus (RV) 2/6-VLP, alone or in the presence of LT-R192G, in order to highlight the differences between the two routes and the impact of the adjuvant. Adult BALB/c mice were immunized once with 2/6-VLP with or without adjuvant and the T cell response was analyzed in lymphoid tissues after in vitro restimulation with the antigen. IN, but not IR, immunization of mice with 2/6-VLP alone induced antigen-specific IL-10 and IL-17 secreting T cells. IL-10-, in contrast to IL-17-, secreting T cells did not migrate to…

Rotavirusmedicine.medical_treatmentT-Lymphocytes[SDV]Life Sciences [q-bio]Priming (immunology)DistributionPHENOTYPEPROTECTSEnterotoxins0302 clinical medicineCell MovementINFECTIONMesenteric lymph nodesHEAT-LABILE TOXINIMMUNE-RESPONSEIL-2 receptorAntigens Viral0303 health sciencesB-LymphocytesMice Inbred BALB CIntrarectalEscherichia coli ProteinsVaccinationFOXP3CHOLERA-TOXINLT-R192G3. Good healthInfectious Diseasesmedicine.anatomical_structureIntranasal030220 oncology & carcinogenesisMolecular MedicineFemaleAdjuvantLymphoid TissueT cellBacterial ToxinsSpleenBiologyMUCOSAL VACCINESRotavirus Infections03 medical and health sciencesCross-PrimingAntigenAdjuvants ImmunologicAdministration RectalVIRUS-LIKE PARTICLESmedicineAnimalsVaccines Virus-Like ParticleImmunity MucosalAdministration Intranasal030304 developmental biologyGeneral VeterinaryGeneral Immunology and MicrobiologyInterleukinsPublic Health Environmental and Occupational HealthRotavirus VaccinesT cellMICEImmunologyCHALLENGE
researchProduct

Les cercles de qualité médecins-pharmaciens, un mode de collaboration vertueux expérimenté en France

2020

S’inspirant du modele suisse, l’unite mixte de developpement professionnel continu sante de l’universite de Bourgogne a mis en place, sur neuf sites, des cercles de qualite medecins-pharmaciens sur le territoire francais. Les resultats, attendus en 2021, permettront d’evaluer l’apport de ces cercles dans differentes organisations de soins primaires et mettront en avant les freins ainsi que les leviers rencontres avant le lancement d’une experimentation plus large.

Pharmacology03 medical and health sciences0302 clinical medicinePharmacology (medical)030212 general & internal medicine030226 pharmacology & pharmacyActualités Pharmaceutiques
researchProduct

GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment

2021

Simple Summary Tumors are not only composed of cancer cells but also of various infiltrating cells constituting the tumor microenvironment (TME); all these cells produce growth factors which contribute to tumor progression and invasiveness. Among them, transforming growth factor-β1 (TGF-β1) has been shown to be a potent immunosuppressive cytokine favoring cell proliferation and invasion and to be associated with resistance to anticancer treatments. Glycoprotein-A repetition predominant (GARP) plays a critical role in the activation of TGF-β1 and has been shown to be expressed at the membrane of cancer cells and also of regulatory T cells and platelets in the TME. An increased GARP expressio…

TGF-βTumor microenvironmentimmunosuppressionGeneral Immunology and MicrobiologyQH301-705.5CancerReviewBiologymedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyBiomarker (cell)Docking (dog)Immune systemGARPCancer researchmedicinecancerbiomarkerBiology (General)General Agricultural and Biological SciencesReceptorFunction (biology)Transforming growth factorBiology
researchProduct

Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

2004

Background Highly publicised outbreaks of norovirus gastroenteritis in hospitals in the UK and Ireland and cruise ships in the USA sparked speculation about whether this reported activity was unusual. Methods We analysed data collected through a collaborative research and surveillance network of viral gastroenteritis in ten European countries (England and Wales were analysed as one region). We compiled data on total number of outbreaks by month, and compared genetic sequences from the isolated viruses. Data were compared with historic data from a systematic retrospective review of surveillance systems and with a central database of viral sequences. Findings Three regions (England and Wales,…

medicine.medical_specialtyvirusesmedicine.disease_causeDisease Outbreaks03 medical and health sciencesEpidemiologyEpidemic spreadmedicineHumans030304 developmental biologyCaliciviridae InfectionsRetrospective Studies0303 health sciencesInternational network030306 microbiologybusiness.industryNorovirusGenetic variantsOutbreakGenetic VariationGeneral MedicineNew variantVirology3. Good healthGastroenteritisEuropePopulation SurveillanceMutationNorovirusFood MicrobiologyViral diseaseSeasonsbusinessLancet (London, England)
researchProduct

The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with 99mTc-Tilmanocept SPECT

2021

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancers and is not eligible for hormone and anti-HER2 therapies. Identifying therapeutic targets and associated biomarkers in TNBC is a clinical challenge to improve patients’ outcome and management. High infiltration of CD206+ M2-like macrophages in the tumor microenvironment (TME) indicates poor prognosis and survival in TNBC patients. As we previously showed that membrane expression of GRP94, an endoplasmic reticulum chaperone, was associated with the anti-inflammatory profile of human PBMC-derived M2 macrophages, we hypothesized that intra-tumoral CD206+ M2 macrophages expressing GRP94 may represent innovative…

QH301-705.5GRP94M2-like macrophages03 medical and health sciences0302 clinical medicineBreast cancerIn vivoSpect imagingmedicineBiology (General)Triple-negative breast cancerGRP94; M2-like macrophages; triple-negative breast cancer; PU-WS13; SPECT imaging; biomarker; CD206; Tilmanocept030304 developmental biology0303 health sciencesTumor microenvironmentSPECT imagingbusiness.industryGeneral Medicinemedicine.diseasePU-WS133. Good health030220 oncology & carcinogenesisCancer researchtriple-negative breast cancerBiomarker (medicine)biomarkerbusinessCD8HormoneCells
researchProduct

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in…

2003

We investigated the immune response induced by mucosal immunization of BALB/c mice with virus-like particles (VLPs) of a genogroup II norovirus, Dijon171/96 virus, produced in the baculovirus system. VLPs administered alone by the intranasal route induced a high serum antibody response as well as fecal IgA, which were enhanced when the heat-labile Escherichia coli toxin or its non toxic mutant LT(R192G) was coadministered. In these conditions, the oral route was also efficient. Cytokine production by cells from different lymphoid tissues was then assessed after in vitro restimulation. A Th1/Th2-like response was observed in cervical lymph node and Peyer's patch (PP) cell cultures from mice …

Cellular immunityvirusesmedicine.medical_treatmentAdministration OralEnzyme-Linked Immunosorbent AssayAntibodies ViralBALB/cMicrobiologyFecesMiceTh2 CellsImmune systemAdjuvants ImmunologicVirus-like particlemedicineAnimalsAdministration IntranasalCells CulturedImmunity CellularMice Inbred BALB CVaccines SyntheticGeneral VeterinaryGeneral Immunology and MicrobiologybiologyNorovirusPublic Health Environmental and Occupational HealthViral VaccinesTh1 Cellsbiology.organism_classificationVirologyInfectious DiseasesCytokineAntibody FormationHumoral immunitybiology.proteinMolecular MedicineFemaleLymph NodesAntibodyAdjuvantSpleenVaccine
researchProduct

Virus diversity in a winter epidemic of acute diarrhea in France.

2002

ABSTRACT In France, an epidemic peak of acute diarrhea is observed each winter. Previous results suggested a viral etiology for these winter epidemics. We investigated the role of enteric viruses in acute diarrhea and their molecular diversity. One hundred sixty-one patients with acute diarrhea and 45 healthy patients (controls) from the general population were given a standardized questionnaire between December 1998 and May 1999. Stool specimens were screened for group A and C rotaviruses, human caliciviruses, astroviruses, and adenovirus types 40 and 41 by reverse transcription-PCR and/or enzyme immunoassay. Virologic analysis was positive for 63 cases (39%). Caliciviruses and group A rot…

RotavirusvirusesAdenoviruses Human/classification/genetics/isolation & purificationmedicine.disease_causeFrance/epidemiologyDisease Outbreaks0302 clinical medicinefluids and secretionsRotavirus030212 general & internal medicineChild0303 health scienceseducation.field_of_studybiologyvirus diseasesMiddle AgedRotavirus/classification/genetics/isolation & purification3. Good healthCaliciviridae/classification/genetics/isolation & purificationDiarrheaVirus DiseasesChild PreschoolVirusesAcute DiseaseViruses/*classification/genetics/isolation & purificationFranceSeasonsmedicine.symptomCaliciviridaeMamastrovirus/classification/genetics/isolation & purificationMicrobiology (medical)DiarrheaAdultAdolescentPopulationReoviridae*Disease OutbreaksVirusAstrovirus03 medical and health sciencesVirologymedicineHumanseducationFecesAged030306 microbiologyDiarrhea/*epidemiology/*virologyAdenoviruses HumanInfant NewbornInfantbiology.organism_classificationVirologyCaliciviridaeVirus Diseases/epidemiology/virology[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]Mamastrovirus
researchProduct

B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP spe…

2015

The purpose of this study was to evaluate the adjuvant effect of the B subunits of cholera toxin (CT) and the thermolabile enterotoxin of Escherichia coli (LT) by the intrarectal route of immunization and compare them to the whole molecules CT and LT-R192G, a non toxic mutant of LT, using 2/6-VLP as an antigen, in mice. All molecules induced similar antigen specific antibody titers in serum and feces, whereas different T cell profiles were observed. CTB and LTB, conversely to CT and LT-R192G, did not induce detectable production of IL-2 by antigen specific T cells. Moreover, CTB, conversely to LT-R192G, CT and LTB, did not induce antigen specific CD4+CD25+Foxp3- and Foxp3+ T cells, thus sho…

RotavirusCholera Toxin[SDV]Life Sciences [q-bio]T cellmedicine.medical_treatmentBacterial ToxinsEnterotoxinBiologymedicine.disease_causeAntibodies ViralMicrobiologyAntibodiesMicrobiologyB subunitEnterotoxinsFecesMiceAntigenAdjuvants ImmunologicImmunologicAdministration RectalmedicineAnimalsViralAdjuvantsIL-2 receptorVaccines Virus-Like ParticleThermolabileB cellVaccinesIntrarectalEscherichia coli ProteinsCholera toxinRotavirus VaccinesLT-R192G3. Good healthVirus-Like ParticleInfectious Diseasesmedicine.anatomical_structureAdministrationAntibody FormationInterleukin-2Th17 CellsImmunizationRectalAdjuvantImmunologic MemoryMicrobial pathogenesis
researchProduct

Low Trough Plasma Concentrations of Nevirapine Associated with Virologic Rebounds in HIV-Infected Patients Who Switched from Protease Inhibitors

2005

BACKGROUND:The substitution of a nonnucleoside reverse-transcriptase inhibitor (NNRTI) for protease inhibitors (PIs) has demonstrated its suitability to maintain virologic response. However, the switch from PIs to an NNRTI could fail for a number of reasons, including NNRTI-associated toxicity and emergence of NNRTI-resistant variants.OBJECTIVE:To describe the virologic failures among 74 HIV-infected patients who switched from PIs to nevirapine.METHODS:Virologic failure was defined as any rebound of the plasma HIV-RNA (pVL) levels >1000 copies/mL on one occasion or 2 consecutive intermittent viremia episodes defined as increases of the pVL >20 copies/mL but <1000 copies/mL. Virolog…

AdultMaleNevirapineHIV InfectionsViremiaImmunopathologyDrug Resistance ViralHumansMedicinePharmacology (medical)Protease inhibitor (pharmacology)NevirapineProspective StudiesSidabiologyReverse-transcriptase inhibitorbusiness.industryHIV Protease InhibitorsMiddle AgedViral Loadbiology.organism_classificationmedicine.diseaseVirologyToxicityHIV-1FemaleViral diseasebusinessFollow-Up Studiesmedicine.drugAnnals of Pharmacotherapy
researchProduct

Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells.

1998

Abstract In this work, we wanted to clarify if differences in antibody (Ab) and particularly in secretory immunoglobulin A (IgA) responses following homologous or heterologous rotavirus infection could be explained by different priming of specific T helper (Th) cells. We compared the Ab responses from suckling BALB/c mice orally inoculated with either a heterologous simian (SA11) or bovine (RF) rotavirus or a homologous murine rotavirus (EHP w ), as well as the profile of cytokines produced by spleen cells after in vitro restimulation. Oral inoculation of EHP w and SA11 induced a similar pattern of Ab with mucosal and serum IgA associated with serum IgG with equal levels of IgG1 and IgG2a, …

CD4-Positive T-LymphocytesDiarrheaRotavirusHeterologousAdministration OralSpleenmedicine.disease_causeAntibodies ViralVirus ReplicationRotavirus InfectionsBALB/cInterferon-gammaMiceImmune systemAntigenSpecies SpecificityPregnancyRotavirusVirologymedicineAnimalsMice Inbred BALB CbiologyImmunogenicityHaplorhinibiology.organism_classificationMolecular biologymedicine.anatomical_structureAnimals NewbornImmunoglobulin A Secretorybiology.proteinCytokinesCattleFemaleAntibodyInterleukin-5SpleenVirology
researchProduct

Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives

2021

SUMMARY Viruses are intracellular parasites that subvert the functions of their host cells to accomplish their infection cycle. The endoplasmic reticulum (ER)-residing chaperone proteins are central for the achievement of different steps of the viral cycle, from entry and replication to assembly and exit. The most abundant ER chaperones are GRP78 (78-kDa glucose-regulated protein), GRP94 (94-kDa glucose-regulated protein), the carbohydrate or lectin-like chaperones calnexin (CNX) and calreticulin (CRT), the protein disulfide isomerases (PDIs), and the DNAJ chaperones. This review will focus on the pleiotropic roles of ER chaperones during viral infection. We will cover their essential role …

GRP78CalnexinReviewGRP94Endoplasmic ReticulumMicrobiologyDNAJcalreticulinImmune systemCalnexinHumansProtein disulfide-isomeraseMolecular BiologyEndoplasmic Reticulum Chaperone BiPchemistry.chemical_classificationbiologyEndoplasmic reticulumIntracellular parasiteprotein disulfide isomeraseCell biologyER chaperoneInfectious DiseaseschemistryApoptosisVirus Diseasesbiology.proteinviral infectionGlycoproteinCalreticulinMolecular ChaperonesMicrobiology and Molecular Biology Reviews : MMBR
researchProduct

Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view.

2001

On entering the host cell the rotavirus virion loses its outer shell to become a double-layered particle (DLP). The DLP then transcribes the 11 segments of its dsRNA genome using its own transcriptase complex, and the mature mRNA emerges along the 5-fold axis. In order to better understand the transcription mechanism and the role of VP6 in transcription we have studied three monoclonal antibodies against VP6: RV-238 which inhibits the transcriptase activity of the DLP; and RV-133 and RV-138 which have no effect on transcription. The structures obtained by cryo-electron microscopy of the DLP/Fab complexes and by X-ray crystallography of the VP6 trimer and the VP6/Fab-238 complex have been co…

Models MolecularRotavirusConformational changeSTRUCTUREMature messenger RNAmedicine.drug_classProtein ConformationvirusesBiologyMonoclonal antibodyAntibodies ViralCrystallography X-RayEpitope03 medical and health sciencesEpitopesImmunoglobulin Fab FragmentsCapsidStructural BiologyTranscription (biology)medicine[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyCRISTALLOGRAPHIE[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyRNA MessengerMolecular BiologyAntigens Viral030304 developmental biology0303 health sciencesMessenger RNA030302 biochemistry & molecular biologyCryoelectron Microscopyvirus diseasesRNADNA-Directed RNA PolymerasesMolecular biologyReverse transcriptase3. Good healthVIROLOGIECapsid ProteinsJournal of molecular biology
researchProduct

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-l…

2001

ABSTRACTWe investigated the rotavirus-specific lymphocyte responses induced by intranasal immunization of adult BALB/c mice with rotavirus 2/6 virus-like particles (2/6-VLPs) of the bovine RF strain, by assessing the profile of cytokines produced after in vitro restimulation and serum and fecal antibody responses. The cytokines produced by splenic cells were first evaluated. Intranasal immunization with 50 μg of 2/6-VLPs induced a high serum antibody response, including immunoglobulin G1 (IgG1) and IgG2a, a weak fecal antibody response, and a mixed Th1/Th2-like profile of cytokines characterized by gamma interferon and interleukin 10 (IL-10) production and very low levels of IL-2, IL-4, and…

Interleukin 2RotavirusCholera ToxinLymphocyteImmunologyBacterial ToxinsBiologymedicine.disease_causeMicrobiologyMicrobiology03 medical and health sciencesEnterotoxinsInterferon-gammaMiceImmune systemTh2 CellsAdjuvants ImmunologicVirologyChlorocebus aethiopsmedicineAnimalsInterferon gammaInterleukin 5Administration Intranasal030304 developmental biology[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesMice Inbred BALB C030306 microbiologyToxinEscherichia coli ProteinsCholera toxinVirionTh1 Cells3. Good healthVIROLOGIEmedicine.anatomical_structureImmunizationInsect Science[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyImmunologyPathogenesis and ImmunityCytokinesInterleukin-2FemaleImmunizationInterleukin-5medicine.drug
researchProduct

Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered …

2007

AbstractSelection of mucosal sites is an important step in mucosal vaccine development. The intrarectal (IR) route represents an alternative to the oral route of immunization; nevertheless, immune responses induced by this route are not well defined. Here, we studied the early primary B cell response (induction, homing, and phenotype) induced by IR immunization with rotavirus (RV)-2/6 virus-like particles (VLP). Using flow cytometry, we traced RV-specific B cells in different lymphoid tissues and analyzed the expression of α4β7 and CCR9, which are important receptors for homing to the gut, as well as CD5, a marker expressed by B1-a cells, which are a major source of natural antibodies. We o…

RotavirusAntibodies ViralMicePeyer's Patches0302 clinical medicineCell MovementImmunology and AllergyMesenteric lymph nodes[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyMesenteryAntigens ViralmucosaB-LymphocytesMice Inbred BALB C0303 health sciencesmedicine.diagnostic_testrodent3. Good healthIntestinesPhenotypemedicine.anatomical_structure[SDV.IMM]Life Sciences [q-bio]/ImmunologyFemaleAntibodyImmunologyReceptors Lymphocyte HomingBiologyCD5 AntigensFlow cytometryReceptors CCR03 medical and health sciencesImmune systemAntigenmedicineAnimalsImmunity MucosalAdministration IntranasalB cell030304 developmental biologyLumbosacral RegionRotavirus VaccinesCell BiologyvaccinationB-1 cellB-1a cellsImmunologybiology.proteinImmunizationLymph Nodescell traffickingCD5030215 immunology
researchProduct

The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.

2016

IF 7.932; International audience; Graft versus host disease (GvHD), which is the primary complication of allogeneic bone marrow transplantation, can alter the intestinal barrier targeted by activated donor T-cells. Chemical inhibition of the stress protein HSP90 was demonstrated in vitro to inhibit T-cell activation and to modulate endoplasmic reticulum (ER) stress to which intestinal cells are highly susceptible. Since the HSP90 inhibitor 17-allylamino-demethoxygeldanamycin (17AAG) is developed in clinics, we explored here its ability to control intestinal acute GvHD in vivo in two mouse GvHD models (C57BL/6 -> BALB/c and FVB/N -> Lgr5-eGFP), ex vivo in intestine organoids and in vitro in …

0301 basic medicineX-Box Binding Protein 1Cancer ResearchLactams MacrocyclicRNA SplicingT-CellsGraft vs Host Disease[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.BC]Life Sciences [q-bio]/Cellular BiologyBiology[ SDV.CAN ] Life Sciences [q-bio]/CancerHsp90 inhibitor03 medical and health sciencesMiceSensitivityInflammatory-Bowel-diseaseGeneticsmedicineBenzoquinonesAnimals[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyNeural progenitor cellsHSP90 Heat-Shock ProteinsIntestinal MucosaStem Cell Niche[ SDV.GEN.GH ] Life Sciences [q-bio]/Genetics/Human genetics[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyMolecular BiologyLeukemia[ SDV.BC ] Life Sciences [q-bio]/Cellular BiologyBone-Marrow-TransplantationMoleculesmedicine.diseaseStem cell niche3. Good healthIre1-AlphaIntestinesMice Inbred C57BL030104 developmental biologyGraft-versus-host diseaseEr Stress[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsCytoprotectionImmunologyMultiple-MyelomaFemaleOncogene
researchProduct

Cholera-Like Enterotoxins and Regulatory T cells

2010

Cholera toxin (CT) and the heat-labile enterotoxin of E. coli (LT), as well as their non toxic mutants, are potent mucosal adjuvants of immunization eliciting mucosal and systemic responses against unrelated co-administered antigens in experimental models and in humans (non toxic mutants). These enterotoxins are composed of two subunits, the A subunit, responsible for an ADP-ribosyl transferase activity and the B subunit, responsible for cell binding. Paradoxically, whereas the whole toxins have adjuvant properties, the B subunits of CT (CTB) and of LT (LTB) have been shown to induce antigen specific tolerance when administered mucosally with antigens in experimental models as well as, rece…

Cholera ToxinHealth Toxicology and Mutagenesismedicine.medical_treatmentBacterial Toxinslcsh:MedicineEnterotoxinReviewBiologyToxicologymedicine.disease_causeT-Lymphocytes Regulatoryregulatory T cellsMicrobiologyImmune toleranceAutoimmune DiseasesEnterotoxinsImmune systemAntigenAdjuvants ImmunologicmedicineImmune ToleranceAnimalsHumansAntigen-presenting cellEscherichia coli Proteinslcsh:RCholera toxinCTBIn vitroLTBImmunologyAdjuvantheat-labile enterotoxin of E. colicholera-like enterotoxinsToxins
researchProduct

Crystallization and Preliminary X-Ray Analysis of Rotavirus Protein VP6

1998

ABSTRACT As a first step to gain insight into the structure of the rotavirus virion at atomic resolution, we report here the expression, purification, and crystallization of recombinant rotavirus protein VP6. This protein has the property of polymerizing in the form of tubular structures in solution which have hindered crystallization thus far. Using a combination of electron microscopy and small-angle X-ray scattering, we found that addition of Ca 2+ at concentrations higher than 100 mM results in depolymerization of the tubes, leading to an essentially monodisperse solution of trimeric VP6 even at high protein concentrations (higher than 10 mg/ml), thereby enabling us to search for crysta…

RotavirusProtein ConformationvirusesRecombinant Fusion ProteinsImmunologyDispersityGene ExpressionTrimerSpodopteraBiologyCrystallography X-RayMicrobiologylaw.inventionchemistry.chemical_compoundCapsidProtein structurelawVirologyAnimal VirusesAnimalsCrystallizationAntigens ViralDepolymerizationResolution (electron density)virus diseasesCrystallographyMonomerBiochemistrychemistryPolymerizationInsect ScienceCapsid ProteinsCattleCrystallizationJournal of Virology
researchProduct

Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion

2001

The structural protein VP6 of rotavirus, an important pathogen responsible for severe gastroenteritis in children, forms the middle layer in the triple-layered viral capsid. Here we present the crystal structure of VP6 determined to 2 A resolution and describe its interactions with other capsid proteins by fitting the atomic model into electron cryomicroscopic reconstructions of viral particles. VP6, which forms a tight trimer, has two distinct domains: a distal beta-barrel domain and a proximal alpha-helical domain, which interact with the outer and inner layer of the virion, respectively. The overall fold is similar to that of protein VP7 from bluetongue virus, with the subunits wrapping …

Models MolecularRotavirusCations DivalentViral proteinvirusesMolecular Sequence DataHemagglutinins ViralTrimerCrystal structureBiologyCrystallography X-Raymedicine.disease_causeProtein Structure SecondaryArticleGeneral Biochemistry Genetics and Molecular BiologyVirus03 medical and health sciencesCapsidRotavirusAtomic modelmedicineAnimalsAmino Acid SequenceAntigens ViralMolecular BiologyPeptide sequence030304 developmental biology0303 health sciencesSequence Homology Amino AcidGeneral Immunology and Microbiology030306 microbiologyViral Core ProteinsGeneral NeuroscienceVirionvirus diseasesMolecular biologyZincCapsidSolventsBiophysicsCapsid ProteinsCattleThe EMBO Journal
researchProduct

Unexpected Modulation of Recall B and T Cell Responses after Immunization with Rotavirus-like Particles in the Presence of LT-R192G

2010

LT-R192G, a mutant of the thermolabile enterotoxin of E. coli, is a potent adjuvant of immunization. Immune responses are generally analyzed at the end of protocols including at least 2 administrations, but rarely after a prime. To investigate this point, we compared B and T cell responses in mice after one and two intrarectal immunizations with 2/6 rotavirus-like particles (2/6-VLP) and LT-R192G. After a boost, we found, an unexpected lower B cell expansion measured by flow cytometry, despite a secondary antibody response. We then analyzed CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) and CD4(+)CD25(+)Foxp3(-) helper T cells after in vitro (re)stimulation of mesenteric lymph node cells …

T-LymphocytesHealth Toxicology and Mutagenesismedicine.medical_treatmentT cellBacterial ToxinsDose-Response Relationship Immunologiclcsh:Medicinechemical and pharmacologic phenomenaBiologyToxicologyArticleregulatory T cellsEnterotoxinsMiceInterleukin 21Immune systemB-1a lymphocyteAdjuvants ImmunologicAntigenmedicineAnimalsIL-2 receptorCD25B cellB-LymphocytesMice Inbred BALB CB lymphocytemucosal immunizationEscherichia coli Proteinslcsh:RRotavirus VaccinesVirionFOXP3LT-R192Ghemic and immune systemsrotavirusmedicine.anatomical_structureFoxp3ImmunologyFemaleImmunizationAdjuvantToxins
researchProduct

Voyage d’étude autour de la pratique officinale suisse

2017

International audience; Twenty-seven students from the Dijon health sciences training and research unit in the 6th year of their course and specialising in the community setting had the opportunity to undertake a study trip to meet Swiss colleagues. They discovered an innovative vision of pharmacy practice. The results of a feedback questionnaire highlighted the benefit of this pedagogical approach for the construction of the professional identity of these future community pharmacists.; L’intégration d’un voyage d’étude dans le cursus pharmaceutique parcours “officine” a permis à 27 étudiants de 6e année de l’unité de formation et de recherche des sciences de santé de Dijon d’aller à la ren…

0301 basic medicinePharmacologymedia_common.quotation_subject030106 microbiologyArt historyArtvaccinationstudy trip03 medical and health sciences[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical sciencesCommunity settingPharmacology (medical)Cercles de qualitépolypharmacy interviewentretien de polymédicationSuisseHumanitiesvoyage d’étudeSwitzerlandnetCare®media_common
researchProduct

Implication des pharmaciens en maisons de santé, résultats d’une enquête

2018

Resume Ces dernieres annees, de nombreux pharmaciens d’officine se sont engages dans des actions interprofessionnelles en soins de premier recours. Dans certains pays, ces dernieres ont fait l’objet d’une evaluation et sont reconnues en tant qu’actes pharmaceutiques pris en charge. En France, l’implication des pharmaciens dans ces actions etait jusqu’alors meconnue. Une enquete realisee aupres de professionnels œuvrant au sein de maisons de sante permet de dresser un premier bilan.

Pharmacology03 medical and health sciences0302 clinical medicinePharmacology (medical)030212 general & internal medicine030226 pharmacology & pharmacyActualités Pharmaceutiques
researchProduct

Molecular Cloning, Expression, Self-Assembly, Antigenicity, and Seroepidemiology of a Genogroup II Norovirus Isolated in France

2003

ABSTRACT Virus-like particles of Dijon171/96 virus, a genogroup II norovirus, were expressed in a baculovirus system and were used for a seroepidemiological study of 1,078 age-stratified human sera collected in Dijon, France. The results showed a seroprevalence of 74.1%. Furthermore, we showed that murine antibodies generated against recombinant Dijon171/96 virus, and human antibodies recognized discontinuous epitopes on the particles.

AdultMicrobiology (medical)AntigenicityAdolescentvirusesMolecular Sequence DataEnzyme-Linked Immunosorbent AssayAntibodies Viralmedicine.disease_causeEpitopeVirusSerologyMiceVirus-like particleSeroepidemiologic StudiesVirologymedicineAnimalsHumansSeroprevalenceCloning MolecularSerotypingChildAgedCaliciviridae InfectionsbiologyInfantMiddle Agedbiology.organism_classificationVirologyCaliciviridaeChild PreschoolImmunoglobulin GSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationNorovirusCapsid ProteinsElectrophoresis Polyacrylamide GelFranceCaliciviridaeJournal of Clinical Microbiology
researchProduct

In vitro reconstitution of rotavirus transcriptional activity using viral cores and recombinant baculovirus expressed VP 6

1993

International audience; Purified baculovirus-expressed group A rotavirus VP6 polypeptide was shown to be active in the recovery of the transcriptase activity associated with the reconstitution of the single-shelled rotavirus particle. Recombinant VP6 polypeptide was able to restore the transcriptional activity in purified viral cores from both SA-11 and RF rotavirus strains. Recombinant group C VP 6 (Cowden strain) is capable of binding as a trimer to group A viral core particles but unable to restore the transcriptase activity, suggesting that the binding of the polypeptide to cores is not the only requirement to restore the transcriptase activity. The VP 6 group A polypeptide was shown to…

RotaviruspolypeptidereplicationTranscription Genetic[SDV]Life Sciences [q-bio]virusesReoviridaeimmunogenicitymedicine.disease_causeViruslaw.inventionCapsidsingle-shelled particlelawVirologyRotavirusGene expressionmedicinebovine rotavirusAntigens ViralPolymerasebiologyViral Core Proteinsvirus diseasesDNA-Directed RNA PolymerasesGeneral Medicinebiology.organism_classificationNucleotidyltransferaseVirologyMolecular biologyRecombinant ProteinsIn vitro[SDV] Life Sciences [q-bio]biology.proteinRecombinant DNACapsid ProteinsElectrophoresis Polyacrylamide GelproteinBaculoviridaeArchives of Virology
researchProduct

Detection and characterization of Human caliciviruses associated with sporadic acute diarrhea in adults in Djibouti (horn of Africa).

2008

International audience; Recent advances in molecular diagnostics have allowed us to recognize Human caliciviruses (HuCVs) as important agents of acute diarrhea in industrialized countries. Their prevalence and genetic diversity in developing countries remains unknown. We report on the characterization of HuCVs among adults presenting acute diarrheas in Djibouti; 108 stool samples collected were screened by EIA, RTPCR, or cell cultures for the group A Rotaviruses, Adenoviruses, Astroviruses, and HuCVs, which were further characterized by genotyping. Among stool samples screened for HuCVs, 25.3% were positive. The other enteric viruses were less prevalent. The 11 HuCV strains sequenced reveal…

MaleAcute diarrheaMESH: CaliciviridaevirusesMESH : DiarrheaFecesfluids and secretionsGenotypeMESH : FemaleMESH: PhylogenyMESH: Caliciviridae InfectionsPhylogenyCaliciviridae Infections[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMESH: Middle AgedMESH: Fecesvirus diseasesMiddle AgedMESH : AdultDiarrheaMESH: DiarrheaInfectious DiseasesMESH : Caliciviridae[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyDjiboutiFemalemedicine.symptomMESH : Caliciviridae InfectionsCaliciviridaeAdultDiarrheaAdolescentMESH : MaleBiology[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyVirusVirologyMESH : AdolescentmedicineHumansMESH : Middle AgedGenotypingMESH: AdolescentGenetic diversityMESH: HumansMESH : HumansMESH : PhylogenyMESH: AdultMESH: DjiboutiMESH : FecesMolecular diagnosticsbiology.organism_classificationVirologyCaliciviridaeMESH: MaleMESH : DjiboutiParasitologyMESH: Female
researchProduct

CCDC 1476682: Experimental Crystal Structure Determination

2017

Related Article: Nicolas Sok, Isabelle Baglin, Christelle Basset, Fatima Fakkor, Evelyne Kohli, Yoann Rousselin, Claire Bernhard, Frédéric Boschetti, Christine Goze, Franck Denat|2017|RSC Advances|7|28291|doi:10.1039/C7RA04218C

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates3-(6-(tetradecahydro-1H-imidazo[15-d][14710]tetraazacyclotridecin-3-yl)pyridin-2-yl)tetradecahydro-1H-imidazo[15-d][14710]tetraazacyclotridecine monohydrate
researchProduct

CCDC 1476683: Experimental Crystal Structure Determination

2017

Related Article: Nicolas Sok, Isabelle Baglin, Christelle Basset, Fatima Fakkor, Evelyne Kohli, Yoann Rousselin, Claire Bernhard, Frédéric Boschetti, Christine Goze, Franck Denat|2017|RSC Advances|7|28291|doi:10.1039/C7RA04218C

Space GroupCrystallographyCrystal System110131620-pentaazatetracyclo[10.10.1.0210.038]tricosa-357-trien-9-oneCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1476681: Experimental Crystal Structure Determination

2017

Related Article: Nicolas Sok, Isabelle Baglin, Christelle Basset, Fatima Fakkor, Evelyne Kohli, Yoann Rousselin, Claire Bernhard, Frédéric Boschetti, Christine Goze, Franck Denat|2017|RSC Advances|7|28291|doi:10.1039/C7RA04218C

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters3-(3-(tetradecahydro-1H-imidazo[15-d][14710]tetraazacyclotridecin-3-yl)phenyl)tetradecahydro-1H-imidazo[15-d][14710]tetraazacyclotridecine monohydrateExperimental 3D Coordinates
researchProduct